Intra or transtympanic corticosteroids can result in significant systemic absorption so consider weaning them in a similar way to oral...
Read moreDetailsIn research which reframes hearing loss as a brain-development issue, not just an ear issue, neuroscientists have found infants born...
Read moreDetailsSouth Korean-based biopharmaceutical company Rznomics Inc is collaborating with Eli Lilly and Company to develop RNA-edited therapeutics for sensorineural hearing...
Read moreDetailsAmerican ENT surgeon, Professor John Oghalai has received funding for a groundbreaking research project to use equipment normally used in...
Read moreDetailsWorld first regenerative cell therapy to replace damaged sensory cells in the inner ear, aiming to restore hearing, is expected...
Read moreDetailsA captioned telephone technology service is offering free infographics on four types of hearing loss for hearing practitioners to give...
Read moreDetailsPeople with sudden hearing loss who receive steroids within seven days are five times more likely to fully recover their...
Read moreDetailsA German otorhinolaryngology research team has developed drug-eluting implants it hopes will be able to treat idiopathic sudden sensorineural hearing...
Read moreDetailsMedChem Australia will support an Ear Science Institute Australia project researching novel small molecules for the treatment of sensorineural hearing...
Read moreDetailsMicrotia Atresia Australia is running three conferences nationwide this year to help families make informed decisions for their school-aged children...
Read moreDetails
Hearing Practitioner Australia is the only independent business-to-business publication for the nation’s hearing industry. The multi-channel platform has been established out of the need for premium, local and independent content relevant to today’s audiologists, audiometrists, otolaryngologists/ENTs and other hearing professionals in Australia.
© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited